This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Robert L. Buchanan
Co-Founder & CEO at Ambulero


Robert is an Entrepreneur-In-Residence at the University of Miami, Florida. He is a co-founder and CEO of Ambulero:  a University of Miami spin-out focused on developing gene and cell therapies for treating vascular disease. He is also a Partner with Ventac Partners where he co-founded and was an early investor in two public companies: Idogen AB and RhoVac AB. Robert was Associate General Counsel with Biogen where responsibilities including supporting Biogen’s growing hemophilia, gene and cell therapy portfolios. Robert received a Ph.D (Biochemistry) from UCLA, a J.D from Suffolk University and he was a Biology Fellow (Neurogenetics) at CALTECH.

Agenda Sessions

  • Panel Discussion: Bridging the Gap between Academia and Commercialisation: When to spin out?